TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
BNR

Burning Rock Biotech Ltd

Healthcare · Diagnostics & Research

16.00$ -9.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

Burning Rock Biotech Ltd (BNR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 135 million CNY. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement BNR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
128 121 126 136 129 126 133 149 132 125 108 135 499
42 43 40 40 37 37 36 40 33 27 30 37 127
86 78 86 95 92 89 97 108 99 97 78 98 372
84 73 66 65 49 52 40 50 41 34 28 31 135
119 122 99 93 33 84 31 31 32 76 28 37 173
265 244 212 207 130 173 113 120 115 109 97 116 437
-179 -166 -126 -111 -39 -47 -15 -11 -16 -12 -19 -18 -65
– – – – 0.0 – 0.0 – 0.0 0.0 0.0 0.0 0.1
-175 -161 -121 -108 -36 -76 -13 -9.5 -17 -14 -17 -18 -66
0.5 1.1 0.2 0.2 0.2 – 0.2 0.2 0.2 0.9 0.2 0.3 1.6
-175 -162 -122 -108 -36 -81 -14 -9.7 -17 -15 -17 -18 -68
-144 -148 -89 -108 -2.7 – -13 3.4 -17 -9.1 -17 -16 -59

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?